skip to Main Content
Anti Depressant

RESTORx ANTI-DEPRESSANT SUPPORT

Are you on anti-depressant medication (known as SSRIS and SNRIS) and experiencing side effects such as:

  • Low Libido or sexual desire
  • Altered Appetite
  • Low energy

Did you know?
Up to 60 % of individuals on anti-depressants are not adherent to their medication.1 Non-adherence remains a common problem and has been widely recognised as one of the reasons for treatment failure in Major Depressive Disorders.1
Medication side effects were one of the major challenges for adhering to treatment.1

Anti-depressant support contains natural ingredients, that may reduce the impact of side-effects, encouraging adherence to prescription medication.

SOLAL® RestorX Anti-Depressant Support has 4 hero ingredients, in their optimal doses, to restore, reduce and oppose side effects caused by anti-depressant medication.

Low Libido / Sexual Dysfunction

Maca treatment may improve libido in women with anti-depressant induced sexual dysfunction. Alleviate SSRi-induced sexual dysfunction in postmenopausal women. Improve sexual desire in men.

Maca

Weight Gain

Chromium contributes to the maintenance of normal blood glucose levels and helps the body metabolise carbohydrates and fats.

Chromium

Fatigue

Vitamin B12 supports the nervous system and contributes to the reduction of tiredness and fatigue.

Vit B12

Fatigue

Folate is a vitamin supplement necessary for the normal production of red blood cells.

Folate

RESTORx ANTI-DEPRESSANT SUPPORT

To be used in conjunction with prescribed anti-depressant medicines, to reduce their side effects by restoring medication-induced nutrient deficiencies.

Each Capsule Contains Amount Available in RESTORx Anti-Depressant Support
Maca (Lepidum meyenii) 150 mg
Chromium (Chromium polynicotinate) 50 μg
Vitamin B6 (Pyridoxine hydrochloride) 10 mg
Vitamin B12 (Methylcobalamin form) 100 μg
Vitamin D3 1000 IU
Folate (L-5-Methyltetrahydrofolate) 500 μg


DOSE: Adults: Take one softgel capsule with or shortly after a meal.
Anti Depressant support

For full prescribing information, refer to the package insert/product information approved by the regulatory authority. This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.

References:
      1. Treatment | Anxiety and Depression Association of America. Accessed on August 2018. Available on https://adaa.org/finding-help/treatment.
      2. South Africa A Heaven For Anxiety Disorders. Accessed on August 2018. Available on http://www.sadag.org/index.php?option=com_content&view=article&id=577:south-africa-a-heaven-for-anxiety-disorders&catid=78&Itemid=161.
      3. Staner, L. 2003. Sleep and anxiety disorders. Dialogues in Clinical Neuroscience. 5(3):249-258.
      4. Locke, A.B., Kirst, N. et al. 2015. Diagnosis and Management of Generalized Anxiety Disorder and Panic Disorder in Adults. American Family Physician. 91(9):618-624.
      5. Bandelow, B., Sher, L. et al. 2012. Guidelines for the pharmacological treatment of anxiety disorders, obsessive – compulsive disorder and posttraumatic stress disorder in primary care International Journal of Psychiatry in Clinical Practice. 16: 77–84.
      6. Alberti, S., Chiesa, A. et al. 2015. Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a metaanalysis. J Clin Psychopharmacol. 35(3):296-303.
      7. Mayers, A.G., and Baldwin, D.S. 2015. Antidepressants and their effect on sleep. Hum Psychopharmacol Clin Exp. 20: 533–559.
      8. Wichniak, A., Wierzbicka, A. et al. 2012. Sleep and antidepressant treatment. Curr Pharm Des. 18(36):5802-17.
      9. Paredes, S.D., Barriga, C. et al. 2009. Assessment of the Potential Role of Tryptophan as the Precursor of Serotonin and Melatonin for the Aged Sleep-wake Cycle and Immune Function: Streptopelia Risoria as a Model. International Journal of Tryptophan Research. 2:23–36.
      10. Cajochen, C., Kra ̈uchi, K. et al. 2003. Role of Melatonin in the Regulation of Human Circadian Rhythms and Sleep Journal of Neuroendocrinology. 15:432–437.
      11. Davison K.M., Chandrasekera, U. et al. 2012. The Role of Nutrition in Mental Health Promotion and Prevention (1). Toronto: Dietitians of Canada, 2012. Access on August 2018. Available on www.dietitians.ca/mentalhealth.
Back To Top